The Atopic Dermatitis (AD) drugs market in the US is experiencing a significant boom, driven by a confluence of medical innovation and increased patient awareness. Valued at a robust USD 17.46 billion in 2023, the market is poised for exceptional expansion. Projections indicate a climb to USD 18.85 billion in 2024, leading to a striking forecast of USD 34.76 billion by 2031. This stellar...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek